Immutep Reaches Enrolment Target for INSIGHT-003 Trial in 1st Line NSCLC

Monday, February 6, 2023 1 min read

Key Takeaway: Immutep Reaches Enrolment Target for INSIGHT-003 Trial in 1st Line NSCLC